Opportunity Information: Apply for PAR 20 153

The NIH Science Education Partnership Award (SEPA) is a National Institutes of Health (NIH) Research Education Program grant mechanism (R25) designed to support science education and research education activities that align with NIH mission areas. The central purpose of this opportunity is workforce-focused: it funds educational efforts that complement and strengthen the training pipeline needed to meet the United States' biomedical, behavioral, and clinical research needs. This particular funding announcement is explicitly labeled "Clinical Trial Not Allowed," meaning applicants cannot propose projects that include clinical trials as defined by NIH policy; the work must stay on the education and research education side rather than testing clinical interventions in humans.

In practice, SEPA supports projects that improve science literacy, broaden participation in biomedical research, and build stronger pathways into research careers by creating or enhancing educational programs. While the specific program priorities and allowable activities are detailed in the full Funding Opportunity Announcement (FOA), the framing emphasizes initiatives that expand educational access and quality, often through partnerships among schools, higher education institutions, community organizations, and research-intensive environments. NIH also points applicants to examples of active and past SEPA projects as a way to understand typical project models and expectations; these can be reviewed through NIGMS and the broader SEPA community sites (https://www.nigms.nih.gov/Research/crcb/sepa/Pages/default.aspx and http://nihsepa.org).

A notable feature of this opportunity is the strong encouragement for applicants to communicate early with the SEPA Scientific/Research Contact. That pre-submission conversation is meant to help an organization assess whether its concept fits SEPA program objectives and, importantly, the priorities of the National Institute of General Medical Sciences (NIGMS), which is the NIH institute commonly associated with SEPA. This kind of consultation can help applicants avoid misalignment (for example, proposing activities outside the education scope or including elements NIH would consider a clinical trial).

Eligibility is broad and spans many types of U.S.-based organizations and government entities. Eligible applicants listed for this opportunity include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (both with and without 501(c)(3) status, as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; small businesses; and other entities as permitted under the FOA. The opportunity also highlights categories of organizations that are specifically welcome as "other eligible applicants," including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations. It also includes certain tribal and regional entities and U.S. territories or possessions, reflecting an emphasis on reaching diverse communities and strengthening education pathways across different regions and populations.

At the same time, there are clear restrictions related to foreign participation. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In other words, applicants must be U.S.-based and must structure the project so that it does not rely on foreign components as part of the proposed work.

From an administrative standpoint, the opportunity is a discretionary grant under the health funding activity category, with CFDA number 93.859, and it is offered by the National Institutes of Health. The funding opportunity number is PAR-20-153, and the record shows a creation date of March 30, 2020. The listed award ceiling is $250,000 (as presented in the source data). The source data also includes an original closing date of July 13, 2022, which indicates that applicants should verify the current status, deadlines, and any reissued or updated versions of the FOA on NIH or Grants.gov, since NIH opportunities are often renewed, amended, or replaced over time.

Overall, SEPA (R25) is best understood as NIH support for education-centered projects that strengthen the pipeline into biomedical and related research fields, frequently through partnerships and scalable educational programming, with a strong emphasis on alignment with NIGMS/SEPA priorities, broad organizational eligibility within the U.S., and strict prohibitions on clinical trials and foreign components.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
  • This funding opportunity was created on 2020-03-30.
  • Applicants must submit their applications by 2022-07-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 20 153

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Science Education

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Previous opportunity: Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 20 153

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 20 153) also looked into and applied for these:

Funding Opportunity
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) Apply for PAR 20 156

Funding Number: PAR 20 156
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) Apply for PAR 20 157

Funding Number: PAR 20 157
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for PAR 20 158

Funding Number: PAR 20 158
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) Apply for PAR 20 159

Funding Number: PAR 20 159
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Furthering Health System Reforms in Ukraine Apply for RFI 121 20 000001

Funding Number: RFI 121 20 000001
Agency: Ukraine USAID-Kiev
Category: Health
Funding Amount: Case Dependent
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Exploratory/Developmental Research Projects (UH2 Clinical Trial Optional) Apply for RFA AA 20 008

Funding Number: RFA AA 20 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $175,000
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 20 525

Funding Number: RFA MH 20 525
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 070

Funding Number: PA 20 070
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) Apply for RFA HS 20 003

Funding Number: RFA HS 20 003
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) Apply for RFA AI 20 029

Funding Number: RFA AI 20 029
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required) Apply for RFA HL 22 006

Funding Number: RFA HL 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 20 019

Funding Number: RFA RM 20 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Noninvasive mTBI Tool RFI Apply for HU000120R0047

Funding Number: HU000120R0047
Agency: Uniformed Services Univ. of the Health Sciences
Category: Health
Funding Amount: Case Dependent
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) Apply for PAR 20 175

Funding Number: PAR 20 175
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed). Apply for RFA AI 20 027

Funding Number: RFA AI 20 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Apply for PA 20 072

Funding Number: PA 20 072
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Apply for PAR 20 178

Funding Number: PAR 20 178
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) Apply for PAR 20 177

Funding Number: PAR 20 177
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) Disease Modifying Therapies for Chronic Lung Diseases (U24 Clinical Trial Required - Infrastructure) Apply for RFA HL 21 012

Funding Number: RFA HL 21 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required) Apply for RFA HL 21 013

Funding Number: RFA HL 21 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 153", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: